{{Rsnum
|rsid=2253319
|Gene=RUNX1
|Chromosome=21
|position=34815749
|Orientation=plus
|GMAF=0.4086
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=RUNX1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 50.4 | 42.5 | 7.1
| HCB | 39.0 | 45.6 | 15.4
| JPT | 31.0 | 51.3 | 17.7
| YRI | 19.0 | 50.3 | 30.6
| ASW | 21.1 | 47.4 | 31.6
| CHB | 39.0 | 45.6 | 15.4
| CHD | 32.1 | 55.0 | 12.8
| GIH | 29.7 | 53.5 | 16.8
| LWK | 20.0 | 42.7 | 37.3
| MEX | 51.7 | 31.0 | 17.2
| MKK | 26.3 | 50.6 | 23.1
| TSI | 41.2 | 49.0 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20735389
|Title=Clinical significance of runt-related transcription factor 1 polymorphism in prostate cancer
}}

{{PMID Auto
|PMID=17903305
|Title=A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}